Literature DB >> 12111467

Treatment of Parkinson's with L-DOPA. The early discovery phase, and a comment on current problems.

A Carlsson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12111467     DOI： 10.1007/s007020200064

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN： 0300-9564            Impact factor:   3.575


× No keyword cloud information.
  23 in total

Review 1.  Cannabinoids and neuroprotection in basal ganglia disorders.

Authors:  Onintza Sagredo; Moisés García-Arencibia; Eva de Lago; Simone Finetti; Alessandra Decio; Javier Fernández-Ruiz
Journal:  Mol Neurobiol       Date:  2007-06-23       Impact factor: 5.590

Review 2.  Somatodendritic dopamine release: recent mechanistic insights.

Authors:  Margaret E Rice; Jyoti C Patel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

3.  L-type Ca2+ channel blockers promote Ca2+ accumulation when dopamine receptors are activated in striatal neurons.

Authors:  Molly E Eaton; Wendy Macías; Rachael M Youngs; Anjali Rajadhyaksha; Joshua T Dudman; Christine Konradi
Journal:  Brain Res Mol Brain Res       Date:  2004-11-24

Review 4.  HIV-1 proteins, Tat and gp120, target the developing dopamine system.

Authors:  Sylvia Fitting; Rosemarie M Booze; Charles F Mactutus
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

Review 5.  Age-related changes in motor cortical properties and voluntary activation of skeletal muscle.

Authors:  Brian C Clark; Janet L Taylor
Journal:  Curr Aging Sci       Date:  2011-12

Review 6.  Inhibitory and excitatory neuromodulation by hydrogen peroxide: translating energetics to information.

Authors:  Christian R Lee; Jyoti C Patel; Brian O'Neill; Margaret E Rice
Journal:  J Physiol       Date:  2015-02-27       Impact factor: 5.182

Review 7.  Classification of H₂O₂as a neuromodulator that regulates striatal dopamine release on a subsecond time scale.

Authors:  Jyoti C Patel; Margaret E Rice
Journal:  ACS Chem Neurosci       Date:  2012-11-08       Impact factor: 4.418

8.  Chronic L-dopa decreases serotonin neurons in a subregion of the dorsal raphe nucleus.

Authors:  Branden J Stansley; Bryan K Yamamoto
Journal:  J Pharmacol Exp Ther       Date:  2014-09-11       Impact factor: 4.030

Review 9.  Contribution of β-phenethylamine, a component of chocolate and wine, to dopaminergic neurodegeneration: implications for the pathogenesis of Parkinson's disease.

Authors:  Anupom Borah; Rajib Paul; Muhammed Khairujjaman Mazumder; Nivedita Bhattacharjee
Journal:  Neurosci Bull       Date:  2013-04-10       Impact factor: 5.203

10.  Discovery, Synthesis, and Preclinical Characterization of N-(3-Chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine (VU0418506), a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4).

Authors:  Darren W Engers; Anna L Blobaum; Rocco D Gogliotti; Yiu-Yin Cheung; James M Salovich; Pedro M Garcia-Barrantes; J Scott Daniels; Ryan Morrison; Carrie K Jones; Matthew G Soars; Xiaoliang Zhuo; Jeremy Hurley; John E Macor; Joanne J Bronson; P Jeffrey Conn; Craig W Lindsley; Colleen M Niswender; Corey R Hopkins
Journal:  ACS Chem Neurosci       Date:  2016-05-03       Impact factor: 4.418
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.